The Future of the Global Cardiac Assist Devices Industry, 2025 - Abbott and Medtronic are the Key Vendors


2020-03-04 08:20:10 CISION


The "Cardiac Assist Devices Market - Global Outlook and Forecast 2020-2025" report has been added to's offering. The Global Cardiac Assist Devices Market is expected to grow at a CAGR of over 9% during the period 2019-2025. Key Market Insights The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population. With increased awareness of heart failures among patients and the availability of advanced treatment options, the market is likely to witness growth during the forecast period.The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. The introduction of less invasive devices by surgeons to perform left ventricular assist devices (LVAD) implant surgeries efficiently is leading to promising post-surgical outcomes.Moreover, the global cardiac assist devices market is likely to grow during the forecast period due to increasing technological advancements, new product approvals, increasing elderly population, improvements in reimbursement policies for heart failures, and associated comorbidities. Vendors are likely to focus on addressing unmet patient need as the demands for innovative cardiac assist devices is growing due to promising clinical outcomes, thereby increasing opportunities for vendors.Global Cardiac Assist Devices Market: SegmentationThis research report includes detailed segmentation by Application, Products, End-users and Geography. The application of bridge to transplant (BTT) is enhancing the quality of life and survival chances of patients. The segment is expected to grow steadily due to advances in technology. The entry of advanced and innovative products from first-generation pulsatile flow cardiac assist devices to third-generation continuous flow devices is immensely influencing market growth prospects. However, the segment is likely to witness a decline during the forecast due to the increasing usage of cardiac assist devices as a destination therapy for treating advanced heart failure.Left ventricular assist devices (LVAD) are predominantly used to bridge to transplant and destination therapy compared to other devices. The usage of LVAD has significantly improved the survival rate among patients undergoing heart transplantation. The application of LVADs in patients requiring cardiac support for longer duration enhances the quality of life and survival chances. These factors are likely to influence patients to prefer LVAD implants, thereby bolstering the demand for LVADs.Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures. IABPs provide safer use and earlier intervention to provide hemodynamic support and has minimal complications than other cardiac assist devices.The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth.Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several CVDs, such as vascular stenosis and heart failure. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers. Insights by GeographyThe North American market is expected to grow at the fastest CAGR due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments for such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries. The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. Favorable government policies and increased vendor initiatives in spreading awareness of stents are the other primary factors likely to influence the industry. Insights by VendorsThe global cardiac assist devices market is highly consolidated with major players accounting for a significant share of the industry. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Moreover, they focus on expansion in existing and new industries to cater to the needs of growing customer base, widen their product portfolios, and boost their production capabilities to gain traction from end-users. Leading players are likely to dominate the industry on account of their strong presence and surgeons' endorsement for their products due to the availability of abundant clinical data and efficacy. Key Topics Covered 1 Research Methodology2 Research Objectives3 Research Process4 Scope & Coverage5 Report Assumptions & Caveats5.1 Key Caveats5.2 Currency Conversion5.3 Market Derivation6 Market at a Glance 7 Introduction7.1 Overview7.1.1 Background7.1.2 Cardiac Assist Devices8 Market Dynamics8.1 Market Growth Enablers8.1.1 Growing Global Prevalence/Incidence of Heart Failure8.1.2 Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation8.1.3 Growing Demand for Shared Care Centers & Their Importance Post-LVAD8.2 Market Restraints8.2.1 High Cost of Cardiac Assist Devices8.2.2 Stringent & Time-consuming Regulatory Approvals8.2.3 Complications & Risks Associated with Cardiac Assist Devices8.3 Market Opportunities and Trends8.3.1 Technological Advancements8.3.2 Promising Investigational Cardiac Assist Devices8.3.3 New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices9 Market Landscape9.1 Market Overview9.2 Market Size and Forecast9.3 Five Forces Analysis9.3.1 Threat of New Entrants9.3.2 Bargaining Power of Suppliers9.3.3 Bargaining Power of Buyers9.3.4 Threat of Substitutes9.3.5 Competitive Rivalry10 Product10.1 Market Snapshot & Growth Engine10.2 Market Overview11 Ventricular Assist Devices11.1 Market Snapshot & Growth Engine11.2 Market Overview11.3 Ventricular Assist Devices Market Segmentation by Product11.4 Left-Ventricular Assist Devices11.5 Other Ventricular Assist Devices12 Intra-Aortic Balloon Pump Therapy Devices12.1 Market Overview12.2 Market Size & Forecast13 Total Artificial Heart13.1 Market Overview13.2 Market Size & Forecast14 Application14.1 Market Snapshot & Growth Engine14.2 Market Overview14.3 Bridge to Transplantation (BTT)14.4 Destination Therapy (DT)14.5 Other Applications15 End-users15.1 Market Snapshot & Growth Engine15.2 Market Overview15.3 Hospitals15.4 Specialty Cardiac Centers16 Geography16.1 Market Snapshot & Growth Engine16.2 Overview17 North America18 Europe19 APAC20 Latin America21 Middle East and Africa22 Competitive Landscape22.1 Competition Overview22.2 Market Analysis22.2.1 Ventricular Assist Devices22.2.2 IABP22.2.3 Total Artificial Heart23 Key Company Profiles23.1 Abbott23.2 Medtronic24 Other Prominent Vendors24.1 Abiomed24.2 Berlin Heart24.3 Getinge24.4 Syncardia24.5 Teleflex24.6 Zeon Medical24.7 Tokai Medical Products24.8 SENKO Medical Instrument24.9 Insightra Medical24.10 Reliantheart24.11 Pulsecath24.12 Jarvik Heart For more information about this report visit Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links
“心脏辅助器械市场-全球展望和预测2020-2025”报告已添加到市场研究中。com 的产品。 在2019年至2025年期间,全球心脏辅助器械市场预计将以9%以上的复合年增长率增长。 主要市场见解 由于全球充血性心力衰竭发病率不断上升,尤其是老年人群,心脏辅助器械市场预计将出现显著增长。随着患者对心力衰竭意识的增强和先进治疗方案的可获得性,预测期内市场可能出现增长。新一代心脏辅助装置的出现预计将在预测期内推动行业增长。该行业见证了几个先进和创新的心脏辅助设备的推出,在产品设计和材料使用方面的重大变化。外科医生为进行左室辅助装置( LVAD )植入手术而引进的微创装置有效地提高了手术后的效果。此外,在预测期内,由于技术进步、新产品批准、老年人口增加、心衰报销政策改善以及相关的并发症,全球心脏辅助设备市场可能会增长。供应商可能会专注于解决未满足的患者需求,因为创新心脏辅助设备的需求正在增长,因为有希望的临床结果,从而增加供应商的机会。全球心脏辅助器械市场:细分本研究报告包括应用、产品、最终用户和地理的详细细分。 桥梁在移植中的应用,提高了患者的生活质量和生存机会。由于技术的进步,预计该分部将稳步增长。从第一代脉动心脏辅助装置到第三代连续流量装置的先进创新产品的进入,极大地影响了市场增长前景。然而,由于越来越多地使用心脏辅助设备作为治疗晚期心力衰竭的目的治疗手段,该细分市场在预测期间可能出现下降。左室辅助装置( LVAD )与其他装置相比,主要用于连接移植和目的治疗。LVAD 的应用显著提高了心脏移植患者的生存率。LVADs 在需要长时间心脏支持的患者中的应用,提高了患者的生活质量和生存机会。这些因素可能会影响患者更喜欢 LVAD 植入物,从而支持对 LVAD 的需求。主动脉内气囊泵( IABP )被认为是治疗的第一线,特别是在中低收入国家,并帮助治疗处于关键阶段的患者。由于一些外科医生建议 IABP 治疗晚期心脏衰竭,该领域预计将增长。IABPs 提供更安全的使用和更早的干预,以提供血流动力学支持,并有最小的并发症比其他心脏辅助设备。在预测期内,由于提供心脏护理的医院数量相对较高,医院细分市场预计将占据市场主导地位。病人更喜欢在医院接受先进的心力衰竭治疗,因为他们的位置方便,容易获得。此外,人口老龄化和心脏捐献者短缺是可能推动这一细分市场增长的其他主要因素。特殊心脏中心( SSC )专门用于治疗心血管疾病患者,如血管狭窄和心力衰竭。由于在独立的心脏病学中心提供与 CVD 诊断和高质量治疗相关的复杂基础设施,该细分市场预计将以最快的 CAGR 增长。 地理观察北美市场预计将以最快的复合年增长率增长,因为有利的患者人口统计,有技术的外科医生,以及有利的报销范围。肥胖和糖尿病的日益流行,再加上人口老龄化,增加了心力衰竭,预计这将提振市场。在欧洲,由于患有心脏病的老年人口不断增加,以及对心脏辅助设备优势的高度认识,市场可能会增长。 此外,政府加大对此类设备的投资,可能会推动行业增长。德国、英国和法国是该地区的主要国家,因为它们在研发活动上的投资高于其他欧洲国家。由于医疗支出的增加,加上心血管病的发病率很高,预计亚太经合市场将以温和的速度增长。有利的政府政策和扩大供应商在传播支架意识方面的举措是可能影响行业的其他主要因素。 Vendors 的见解全球心脏辅助设备市场与占行业重要份额的主要厂商高度整合。然而,新进入者有相当大的增长机会。一些调查和小型医疗技术公司有望提供创新的产品和技术。主要参与者正专注于实施产品上市和审批、收购以及增加研发投入等多项战略,以提高其市场份额。 此外,它们注重现有和新行业的扩张,以满足不断增长的客户基础的需求,扩大产品组合,提高生产能力,从终端用户那里获得吸引力。由于拥有丰富的临床数据和疗效,主要参与者可能会因其强大的存在和外科医生对其产品的认可而在行业中占据主导地位。 所涵盖的主要课题 1研究方法2研究目标3研究过程4研究范围和范围5报告假设和漏洞5.1关键漏洞5.2货币兑换5.3市场衍生工具6市场概览 引言7.1概述7.1。背景7.1。协助市场动态8.1市场增长能力。全球心力衰竭患病率/发病率的增加8.1。供者心脏的短缺&心脏移植患者等待名单的增加。共享护理中心需求的增长及其在 LVAD8.2之后的重要性市场限制8.2。心脏辅助魔鬼的高成本。严格和耗时的监管程序8.2。心脏辅助偏差相关的并发症和风险8.3市场机遇和趋势8.3。技术进步。承诺调查心脏辅助魔鬼8.3。现有商业心脏辅助器械的新产品批准和生产线扩展9市场格局9.1市场过度观察9.2市场规模和预测9.3五种力量分析9.3。新入口的门槛。供应商的议价能力。买方的讨价还价能力。替代物的威胁9.3。专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业术语-财务英语词汇专业词汇专业术语-财务英语词汇专业术语-财务英语词汇市场;市场;市场;市场;市场;市场;专业词汇市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场;市场心室辅助装置22.2。2 IABP22.2。3全人工心脏23大公司概况23.1 Abbott23.2 Medtronic24其他主要静脉24.1 Abiomed24.2 Berlin Heart24.3 Geting24.4 Syncarda24.5 Teleflex 24.6 Zeon Medical24.7 Tokai 医疗产品24.8 SENTKO 医疗器械24.9 Insightra Medical24.10 Reliannther24.11 Pulseath24.12 Jarvik 心脏 有关本报告的更多信息,请访问 https://www.research and 研究和市场还提供定制研究服务,提供重点,全面和定制的研究。 媒体联系人: 研究和市场营销 Laura Wood ,高级经理[电子邮件保护]为 E.S.T 办公时间电话+1-917-300-0470为美国/ CAN 免费电话+1-800-526-8630为 GMT 办公时间电话+353-1-416-8900美国传真:646-607-1907传真(外部号码:):+353-1-481-1716 SOURCE 研究与市场 相关链接 http://www.research and